1 – 10 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change
(
- Contribution to journal › Article
-
Mark
Deep learning analysis of serial digital breast tomosynthesis images in a prospective cohort of breast cancer patients who received neoadjuvant chemotherapy
(
- Contribution to journal › Article
- 2023
-
Mark
Obesity and Risk of Recurrence in Patients with Breast Cancer Treated with Aromatase Inhibitors
(
- Contribution to journal › Article
-
Mark
Side effects of low-dose tamoxifen : results from a six-armed randomised controlled trial in healthy women
(
- Contribution to journal › Article
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
(
- Contribution to journal › Article
-
Mark
Effects of tamoxifen on normal breast tissue histological composition : Results from a randomised six-arm placebo-controlled trial in healthy women
(
- Contribution to journal › Article
- 2022
-
Mark
Postmenopausal overweight and breast cancer risk; results from the KARMA cohort
(
- Contribution to journal › Article
-
Mark
Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival
(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article